US EditionMexico Powers Forward with 10.4 Billion in Pharmaceutical Industry Investment
24 Articles
24 Articles
Mexico City, Jul 4 (EFE).- Mexico announced this Friday that it will be betting on the production of generic drugs to reduce prices and improve access to the shortage it suffers, and whose strategy includes the reinstatement of the plant requirement, which requires any pharmaceutical company that wants to sell its products to have at least one factory in the country. “Our goal is to recover the pharmaceutical industry of the country,” Mexico’s p…
The Mexican government seeks to recover the production of generic medicines as one of the objectives to guarantee access to health. From the National Palace, President Claudia Sheinbaum noted that in 2008, in the six-year period of Felipe Calderón, the plant requirement was removed, thus reducing the production of the national pharmaceutical industry, so now it seeks to reverse that situation. "Our goal is to recover, a decree was issued so that…
National pharmaceutical companies will invest 10,48 billion pesos in four projects as part of Plan Mexico for the following years, announced yesterday in the morning of President Claudia Sheinbaum Pardo.
Four Mexican pharmaceutical companies will invest a total of 10,480 million pesos in different projects as part of Plan Mexico, as announced this Thursday by President Claudia Sheinbaum during her morning conference. The goal of this investment, said the president, is to boost the national economy and achieve “sovereignty in pharmaceutical matters so that Mexico can cope with situations of vulnerability such as the pandemic by COVID-19′′. “For u…
More than 65 percent of the medicines and medical inputs used in Mexico are imported, despite the fact that the national pharmaceutical industry represents a market of more than $3.3 billion, Alejandro Svarch, director general of the IMSS-Benestar, revealed this Friday when presenting an analysis of the productive capacity of the country in the health sector. During the morning conference led by President Claudia Sheinbaum, Svarch stressed that …
Mexico is moving towards pharmaceutical sovereignty with a historic investment. On Thursday, July 3, 2025, during the morning presidential conference, President Claudia Sheinbaum and Economy Secretary Marcelo Ebrard announced that four national pharmaceutical companies will invest more than 10 billion pesos (mdp), equivalent to 560 million dollars (mdd), as part of the Mexico Plan to strengthen the pharmaceutical industry in the country. The mea…
Coverage Details
Bias Distribution
- 40% of the sources are Center, 40% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
